Carisma Therapeutics, Inc. Common Stock

Go to Carisma Therapeutics, Inc. Common Stock Website

$0.31

0.00 (-1.12%)
Live
Previous Close

$0.3115

Day Range

$0.3 - $0.315

Previous Day Range

$0.2958 - $0.322

Market Cap

$13.0 million USD

Day Vol.

228741

Previous Day Vol.

397084

Currency

USD

Primary Exchange

Nasdaq

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and oth...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or sales transactions.

Related tickers: CARM, ENZB, HSON, TTNP.

Read Full Article

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches related to merger and sale transactions involving NV5 Global, Carisma Therapeutics, and Heliogen.

Related tickers: NVEE, CARM, HLGN.

Read Full Article
Trending Tickers

Please sign in to view